https://orcid.org/0000-0002-0649-8802
References
- BIO. Biomedtracker, amplion, clinical development success rates 2006–2015; 2016 [cited 2019 Sep 20]. Available from: https://www.bio.org/sites/default/files/Clinical Development Success Rates 2006-2015 - BIO, Biomedtracker, Amplion 2016.pdf
- Allison M. Reinventing clinical trials. Nat Biotechnol. 2012;30(1):41–49.
- Russell WMS, Burch RL. The principles of humane experimental technique. London (UK): Methuen; 1959.
- Bailey J, Balls M. Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations. BMC Med Ethics. 2019;20(1):16.
- Amacher DE. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. Toxicol Appl Pharmacol. 2010;245(1):134–142.
- Bailey J, Thew M, Balls M. An analysis of the use of animal models in predicting human toxicology and drug safety. Altern Lab Anim. 2014;42(3):181–199.
- Bailey J, Thew M, Balls M. Predicting human drug toxicity and safety via animal tests: can any one species predict drug toxicity in any other, and do monkeys help? Altern Lab Anim. 2015;43(6):393–403.
- Balls M, Combes R, Worth A. The history of alternative test methods in toxicology (History of toxicology and environmental health). Cambridge (MA): Academic Press; 2018.